-
Phathom Pharmaceuticals Announces Publication of Data from Phase 3 pHalcon-NERD-301 Study Showing VOQUEZNA® (vonoprazan) Improved Nocturnal GERD Symptoms in Patients with Non-Erosive Reflux Disease
25 Oct 2025 13:59 GMT
… GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT … with vonoprazan in clinical trials and during postmarketing … important drug interactions, including interactions with drugs … About Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals is a …
-
THESE two existing drugs might help enhance brain health, study finds
25 Oct 2025 13:18 GMT
… that two existing diabetes-related drugs, the widely used empagliflozin and … .How the trial worked
The clinical trial involved 47 older adults aged … spray on its own, both drugs combined, or a placebo, over …
-
Study confirms cardiovascular benefits of semaglutide drug beyond weight loss
25 Oct 2025 12:00 GMT
A new analysis of the SELECT trial, the largest and longest clinical trial to date examining the cardiovascular benefits of ‘semaglutide’ — a medication used to support weight loss and diabetes management — confirms it also lowers the risk of major heart …
-
CAGE Bio begins double-blind placebo-controlled clinical trial of topical DNA Aptamer therapy CGB-600 for vitiligo treatment
25 Oct 2025 06:49 GMT
… , double-blind, placebo-controlled clinical trial evaluating its proprietary DNA Aptamer … of vitiligo.
The investigational active pharmaceutical ingredient, licensed from TAGCyx … unmet need. This human clinical trial, where a drug of this size is …
-
Sun Pharma Gets CDSCO Panel Approval to Conduct Phase III Study of Oral Semaglutide
25 Oct 2025 11:35 GMT
… drug major Sun Pharma Laboratories presented the proposal to conduct Phase III clinical trial … Tablets of Sun Pharma Laboratories Limited in … Sun Pharma Laboratories to conduct Phase III clinical trial titled … conduct the Phase III clinical trial as per the …
-
FDA approves non-hormonal drug for menopause hot flashes
25 Oct 2025 10:37 GMT
… ;WKRC) - The Food and Drug Administration has approved Lynkuet, a … that trigger these symptoms.
In clinical trials, women taking Lynkuet reported a … who received a placebo.
The drug is expected to be available …
-
Including pregnant women in drug trials can lead to better health outcomes and reduce misinformation, experts say
25 Oct 2025 09:33 GMT
… eventually discovered that the drug caused serious birth defects … drug was pulled from the market. In the aftermath, clinical trials in … or negative outcomes after drugs come on the market … and breastfeeding people in drug research when appropriate.
A …
-
Biomednewsbreaks - Lantern Pharma Inc. (NASDAQ: LTRN) Advancing Drug Discovery With Predictbbb.Ai(TM) Partnership
25 Oct 2025 06:58 GMT
… , PredictBBB(TM), in streamlining drug development. The platform, boasting … 94% accuracy, predicts whether drug candidates can cross the blood … visit
About Lantern Pharma Inc.
Lantern Pharma is an AI company … to first-in-human clinical trials in 2-3 years …
-
Investornewsbreaks Lantern Pharma (NASDAQ: LTRN) To Present At Thinkequity Conference On Oct. 30
25 Oct 2025 06:58 GMT
… , and timeline of oncology drug discovery, announced that its … release, visit
About Lantern Pharma
Lantern Pharma (NASDAQ: LTRN) is … , and timeline of oncology drug discovery and development. Our … and multiple Phase 1 clinical trials. Our AI-driven pipeline …
-
Investornewsbreaks Nrx Pharmaceuticals Inc. (NASDAQ: NRXP) Advancing Two-Pronged Approach To Bring Innovative Therapies To Market
25 Oct 2025 06:53 GMT
… recently refiled an Abbreviated New Drug Application ('ANDA… its use in injectable drugs, and the FDA … visit
About NRx Pharmaceuticals Inc.
NRx Pharmaceuticals is a clinical- … results of well-controlled clinical trials conducted under the auspices …
About
© 1995-2025